No Data
Kang Wei Century (688426.SH): The 'Kangwei Century Marketing Network Construction Project' has been extended to December 31, 2026.
Kangwei Century (688426.SH) announced on December 4 that the company's second board of directors twelfth meeting and second board of supervisors eleventh meeting held on December 4, 2024 respectively, reviewed and passed the "Proposal on the Postponement of Some Raised Investment Projects", agreed that the expected time for the use of the "Kang Wei Century Marketing Network Construction Project", one of the investment projects funded by the company, will be extended from December 31, 2024, to December 31, 2026. This extension only involves changes in project progress and does not alter the implementation subject, the use of funds raised for investment, and investment rules of the raised investment project.
Kangwei Century (688426.SH): intends to use no more than 0.3 billion yuan of temporarily idle raised funds for cash management.
Gelonghui, December 4th: Kangwei Century (688426.SH) announced that the company plans to use a maximum amount of not more than 0.3 billion yuan of temporarily idle raised funds for cash management. The resolution is valid for 12 months from the expiration date of the last authorization (January 11, 2025), after being approved by the company's board of directors, and can be used in a rolling manner without exceeding the above amount and resolution validity period.
Kangwei Century (688426.SH): The company did not repurchase shares in November.
GeLongHui December 2nd | Kangweicentury (688426.SH) announced that in November 2024, the company did not repurchase shares. As of the close of November 29, 2024, the company has repurchased a total of 2,388,091 shares of the company through the Shanghai Stock Exchange trading system in a centralized bidding trading method, accounting for 2.1229% of the company's total share capital of 112,493,716 shares. The highest repurchase price was 25.68 yuan/share, the lowest price was 15.01 yuan/share, and the total amount paid was RMB 43,642,603.24 (excluding stamp duty, transaction commission).
Concord Medical (688426.SH): H. pylori drug-resistant gene detection kit obtained Class III medical instruments registration certificate.
Kangwei Century (688426.SH) issued an announcement that recently, the company's wholly-owned subsidiary jiangsu Jianwei Diagnostic technology Co., Ltd...
Here's Why We're Not Too Worried About Jiangsu CoWin Biotech's (SHSE:688426) Cash Burn Situation
2024 Third Quarter Report
Jiangsu CoWin Biotech Co., Ltd.'s (SHSE:688426) 37% Share Price Plunge Could Signal Some Risk
No Data
